JESBEE Trademark

Trademark Overview


On Tuesday, December 20, 2022, a trademark application was filed for JESBEE with the United States Patent and Trademark Office. The USPTO has given the JESBEE trademark a serial number of 97725225. The federal status of this trademark filing is REGISTERED as of Tuesday, November 12, 2024. This trademark is owned by Glaxo Group Limited. The JESBEE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives available by prescription only; Pharmaceutical preparations and substances for the treatment of damaged tissue, namely, nervous tissue, muscle tissue, and connective tissue, available by prescription only; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders available by prescription only; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders available by prescription only
jesbee

General Information


Serial Number97725225
Word MarkJESBEE
Filing DateTuesday, December 20, 2022
Status700 - REGISTERED
Status DateTuesday, November 12, 2024
Registration Number7561919
Registration DateTuesday, November 12, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2024

Trademark Statements


Goods and ServicesVaccines; Anti-infectives available by prescription only; Pharmaceutical preparations and substances for the treatment of damaged tissue, namely, nervous tissue, muscle tissue, and connective tissue, available by prescription only; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders available by prescription only; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders available by prescription only

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Friday, December 23, 2022NEW APPLICATION ENTERED
Tuesday, January 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 19, 2023ASSIGNED TO EXAMINER
Wednesday, September 27, 2023NON-FINAL ACTION WRITTEN
Wednesday, September 27, 2023NON-FINAL ACTION E-MAILED
Wednesday, September 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 3, 2023SUSPENSION LETTER WRITTEN
Friday, November 3, 2023LETTER OF SUSPENSION E-MAILED
Friday, November 3, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 15, 2024EXAMINER'S AMENDMENT ENTERED
Monday, July 15, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 15, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, July 15, 2024EXAMINERS AMENDMENT E-MAILED
Friday, May 3, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, July 18, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, August 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 27, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED